Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trial

Introduction: Dose escalation to dominant intraprostatic lesions (DILs) is a novel method to increase the therapeutic ratio in localised prostate cancer. The Stereotactic Prostate Augmented Radiotherapy with Cyberknife (SPARC) trial was designed to determine the feasibility of a focal boost defined...

全面介紹

書目詳細資料

Principais autores:	Luke Nicholls, Yae-eun Suh, Ewan Chapman, Daniel Henderson, Caroline Jones, Kirsty Morrison, Aslam Sohaib, Helen Taylor, Alison Tree, Nicholas van As
格式:	Artigo
語言:	Inglês
出版:	Elsevier 2020-11-01
叢編:	Clinical and Translational Radiation Oncology
主題:	Intermediate- and high-risk Prostate cancer Radiotherapy Stereotactic ablative body radiotherapy
在線閱讀:	http://www.sciencedirect.com/science/article/pii/S2405630820300847
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!